Companies in #Melanoma

Huyabio International is a clinical-stage biopharmaceutical company developing novel small molecule oncology therapeutics. Lead program HBI-8000 (tucidinostat) is an HDAC inhibitor that has demonstrated Phase 3 success in melanoma and is approved in China for multiple oncology indications.